Quent Capital’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$24.8K	Sell	188 -57	-23%	-$7.56K	﹤0.01%	920
2025 Q4	$34.7K	Buy	245 +14	+6%	+$2.03K	﹤0.01%	847
2025 Q3	$32.4K	Buy	+231	New	+$31.3K	﹤0.01%	731
2025 Q2	–	Sell	-74	Closed	-$8.18K	–	902
2025 Q1	$8.18K	Hold	74	–	–	﹤0.01%	939
2024 Q4	$10.1K	Sell	74 -84	-53%	-$10.4K	﹤0.01%	933
2024 Q3	$18.2K	Hold	158	–	–	﹤0.01%	902
2024 Q2	$21.8K	Hold	158	–	–	﹤0.01%	821
2024 Q1	$21.8K	Buy	158 +117	+285%	+$16K	﹤0.01%	857
2023 Q4	$5.4K	Buy	41 +32	+356%	+$3.68K	﹤0.01%	1059
2023 Q3	$1.01K	Hold	9	–	–	﹤0.01%	1240
2023 Q2	$849	Hold	9	–	–	﹤0.01%	1251
2023 Q1	$911	Hold	9	–	–	﹤0.01%	1246
2022 Q4	$1.07K	Hold	9	–	–	﹤0.01%	1222
2022 Q3	$1K	Hold	9	–	–	﹤0.01%	1166
2022 Q2	$1K	Sell	9 -100	-92%	-$9.23K	﹤0.01%	1118
2022 Q1	$10K	Buy	109 +100	+1,111%	+$8.47K	﹤0.01%	910
2021 Q4	$1K	Buy	+9	New	+$828	﹤0.01%	1046